Patents by Inventor Gerard Ribes

Gerard Ribes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof
    Patent number: 8404746
    Abstract: The present invention relates to the use of chicoric acid and/or at least one of these metabolites selected among mono-caffeoyl-tartaric acid and/or m-hydroxyphenylpropionic acid, and/or 4-vinylcatechol and/or 4-ethylcatechol for manufacturing a composition intended for prevention or treatment in an insulin-resistant patient or hypoinsulinemia and/or associated pathologies.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: March 26, 2013
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Claude Andary, Gérard Ribes, Didier Tousch, Jacqueline Azay-Milhau, Anne-Dominique LaJoix
  • ANTI-DIABETES COMPOSITION CONTAINING CHICORIC ACID AND/OR ONE OF THE METABOLITES THEREOF
    Publication number: 20110015140
    Abstract: The present invention relates to the use of chicoric acid and/or at least one of these metabolites selected among mono-caffeoyl-tartaric acid and/or m-hydroxyphenylpropionic acid, and/or 4-vinylcatechol and/or 4-ethylcatechol for manufacturing a composition intended for prevention or treatment in an insulin-resistant patient or hypoinsulinemia and/or associated pathologies.
    Type: Application
    Filed: August 17, 2007
    Publication date: January 20, 2011
    Inventors: Claude Andary, Gérard Ribes, Didier Tousch, Jacqueline Azay-Milhau, Anne-Dominique Lajoix
  • Use of Amino Acids for Making Medicines for Treating Insulin Resistance
    Publication number: 20080287344
    Abstract: The invention concerns the use of monohydroxy or polyhydroxy amino acids, and the lactone forms thereof for making medicines with insulin-analogue and/or insulin-sensitizing effects on peripheral tissues targeted by insulin, and more particularly the use thereof for making medicines for treating and preventing insulin-resistance.
    Type: Application
    Filed: July 21, 2008
    Publication date: November 20, 2008
    Applicant: Innodia Inc.
    Inventors: Gerard Ribes, Mohammed Taouis, Roger Pierre Petit, Christophe Broca, Yves Sauvaire, Bernard Pau
  • Use of amino acids for making medicines for treating to insulin-resistance
    Patent number: 7402611
    Abstract: The invention concerns the use of monohydroxy or polyhydroxy amino acids, and the lactone forms thereof for making medicines with insulin-analogue and/or insulin-sensitizing effects on peripheral tissues targeted by insulin, and more particularly the use thereof for making medicines for treating and preventing insulin-resistance.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: July 22, 2008
    Assignee: Innodia Inc.
    Inventors: Gérard Ribes, Mohammed Taouis, Roger Pierre Petit, Christophe Broca, Yves Sauvaire
  • Use of hydroxylated amino acids for treating diabetes
    Publication number: 20070004623
    Abstract: This invention relates to methods and compositions for treating diabetes, which involve the use of hydroxylated amino acids, such as 4-hydroxyisoleucine, and one or more additional antidiabetic agents.
    Type: Application
    Filed: October 27, 2004
    Publication date: January 4, 2007
    Applicant: Innodia Inc.
    Inventors: Francesco Bellini, Claude Vezeau, Gerard Ribes, Nicolas Chapal, Mark Prentki
  • Novel method for screening inhibitors of the linkage between the neuronal nitric oxide synthase associated protein and the protein inhibiting neuronal nitric oxide synthase
    Publication number: 20050019854
    Abstract: The invention concerns a detection procedure for compounds modulating the complexation between neuronal nitric oxide synthase protein (nNOS) or one of its variants and the protein inhibitor of neuronal nitric oxide synthase (PIN), in which: a mixture of the said compound, the PIN and the nNOS or one of its variants is incubated, significant variation in the quantity of complex formed between the PIN and the nNOS or one of its variants with respect to a control value is detected, when there is significant variation as defined above, it is concluded that there is binding between the said compound and the PIN, or between the said compound and the nNOS or one of its variants, leading to modulation of the complexation between the PIN and nNOS or one of its variants.
    Type: Application
    Filed: April 17, 2002
    Publication date: January 27, 2005
    Inventors: Rene Gross, Anne-Dominique Lajoix, Gerard Ribes
  • Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil and sitosterol
    Publication number: 20040028759
    Abstract: The present invention relates to a pharmaceutical or dietary composition containing, as active principle, a mixture comprising:
    Type: Application
    Filed: September 8, 2003
    Publication date: February 12, 2004
    Inventors: Jean-Claude Maurel, Gerard Cros, Gerard Ribes
  • Treatment of non-insulin-dependent diabetes
    Patent number: 5470879
    Abstract: Antidiabetic composition, characterized in that it contains as active substance, in the free or combined state, at least one mono- or polyhydroxylated amino acid and/or its lactone forms and its amidated derivatives.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: November 28, 1995
    Assignee: Laboratories Monal
    Inventors: Yves Sauvaire, Gerard Ribes